Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. - Wikidata - wikimedia - TriplyDB

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

http://www.wikidata.org/entity/Q33398473

about

Update in lung cancer and mesothelioma 2012 Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study The long-term prognosis of induction chemotherapy followed by surgery for N2 non-small cell lung cancer: A retrospective case series study.Adjuvant or neoadjuvant chemotherapy for NSCLC.The Role of Neoadjuvant Trials in Drug Development for Solid Tumors.The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer PACE Continuous Innovation Indicators-a novel tool to measure progress in cancer treatments.Galectin-4, a novel predictor for lymph node metastasis in lung adenocarcinoma Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status.Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisal The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes.A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma.Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery.Minimally invasive (robotic assisted thoracic surgery and video-assisted thoracic surgery) lobectomy for the treatment of locally advanced non-small cell lung cancer Feasibility of complete video-assisted thoracoscopic surgery following neoadjuvant therapy for locally advanced non-small cell lung cancer.Perioperative outcomes and lymph node assessment after induction therapy in patients with clinical N1 or N2 non-small cell lung cancer Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.Recurrence after surgery in patients with NSCLC.Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: What is the role for surgery?Preoperative predictors of distant recurrence in patients with clinical stage IA lung adenocarcinoma undergoing complete resection.Time-to-event endpoints in operable non-small-cell lung cancer randomized clinical trials.Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer.Peripheral CD4+ naïve/memory ratio is an independent predictor of survival in non-small cell lung cancer.Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab.Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study.Neoadjuvant chemotherapy followed by surgery versus upfront surgery in non-metastatic non-small cell lung cancer: systematic review and meta-analysis of randomized controlled trials.Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.

P2860

Q24619675-17B5B2C5-3143-48B4-917E-7F524DC0C18D Q26863742-6CB8ADFA-0DCA-47A7-8CCB-E6CE53B065ED Q27002509-6DA99A24-8842-46F2-9313-737B2D4FA50F Q27010262-E80AF293-B7BF-4E57-B165-DC4249AEF59F Q28552143-57F1A398-9F64-4D63-86E3-1CD04CF2838D Q33417372-F4FB4AC2-C6F9-4015-8F99-AB574BD4E469 Q33613087-E7C77B46-6EF2-4D78-8B07-9B77A945A92F Q33658228-741B319D-CA17-4FC3-9DBF-F9599C97FB86 Q33886353-23391767-5026-4579-8C17-CB4F85BB5AC3 Q34720945-E2CB394D-A166-4DD9-A992-51F825218AC8 Q34814550-6B0660B6-C443-4AFC-A51E-9C7F28EACA8A Q35002591-2908353C-6EF3-4EE7-915C-439057E5C0AD Q35067654-A29D396F-3392-4A4C-A649-E982DAF25287 Q35644940-BA26130D-0C48-487B-BDCC-8A68604ECFFF Q35681695-5C08E01C-2246-406B-942B-6797456109EB Q36247875-9B79A89C-E3FF-432C-8259-85935FEB54B2 Q36308285-C5F9FEBA-669E-40CD-9304-8E187FA65EB8 Q36525431-1AFBD33E-BC45-41E9-9ADA-00EEC64F37BA Q36731328-2077D333-A799-4339-88E9-4D652D719FC2 Q36733598-AAB9F386-02AE-4E57-A0AB-4039577C84DB Q36752521-C2134065-7483-4F34-828C-883393E69508 Q36814881-1AB7616D-1B05-44E8-891E-2BA0675088D7 Q36850130-99CD6DB3-5F61-4450-9D0F-B357C2F8B493 Q36870165-4B05D1CB-F291-4A9B-8500-9DA54F6DCE80 Q37167056-D7E94F35-FF10-422B-9047-206A1D1F8095 Q37208623-ECB4750C-1810-44CF-83CE-8D2DF6AE74D0 Q37478345-9C1F660F-5A53-4C88-AEC4-B945D63CEC77 Q38390164-A568FE9E-CDE2-4B77-837C-13A9F6963AF4 Q38696794-1C02B329-074A-4B6A-AE36-7FC5372F9F60 Q38818969-70A65979-84D7-48A0-A21B-44D30493003F Q38973825-50168AE1-295D-4FC5-A30A-D11CDD890E46 Q39034554-12F73740-6297-406F-992B-B8EC0F5EE318 Q42362645-4F0CA2E6-F1D8-4457-9AA3-C0F30DBE6E63 Q45223931-88504EED-F50E-4F31-97E8-B024856269F5 Q45794075-BCC0684E-7F2D-4140-AA4C-9E7A8EA6C470 Q45959320-508E1263-E068-48E7-8FCD-EDB7A801D5AE Q46173157-8C3668AC-0EAE-4E57-B42D-474322800EDC Q47122526-734E41C2-E666-4BA9-8DB0-356CC001267E Q47137416-D68C4D97-6EDF-4B3D-BDD6-B001503AF455 Q47191741-09D5C512-5830-4828-88B9-95FFA49EF8C4

P2860

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

http://www.wikidata.org/entity/Q33398473

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Randomized phase III study of ...... IA non-small-cell lung cancer.

@ast

Randomized phase III study of ...... IA non-small-cell lung cancer.

@en

type

label

Randomized phase III study of ...... IA non-small-cell lung cancer.

@ast

Randomized phase III study of ...... IA non-small-cell lung cancer.

@en

prefLabel

Randomized phase III study of ...... IA non-small-cell lung cancer.

@ast

Randomized phase III study of ...... IA non-small-cell lung cancer.

@en

P1433

Q33398473-666A99EA-3E8C-48A8-88DE-7F5581470279

P1476

Q33398473-53FF433C-FFA9-456A-A874-463E831B3CD0

P2093

Q33398473-56B2760A-DF55-4950-901B-511AAF7BF80A

Q33398473-67575021-87DE-4A15-A496-C929652C98A9

Q33398473-6F6A7729-8A25-4D5B-A8C4-D67400725E9A

Q33398473-946AA19F-B98C-4583-A20D-F4A1B9AAA4B6

Q33398473-95C2AA3B-2AF8-407C-896A-FC6D7543E722

Q33398473-9A041FAB-27DF-42C5-94D2-692F619374EC

Q33398473-A43876DF-731F-4ECE-9933-A6FAA2B2391D

Q33398473-CD18FFB0-FE38-4048-AB6D-C2BC3BD8DF04

Q33398473-F703A753-FF8E-408B-A1C1-736F37935808

P304

Q33398473-D0FE4B69-35F4-47EE-BFA5-A120F0411DB0

P31

Q33398473-C4C83A19-BABB-4BFB-B9DB-BAE113A56244

P356

Q33398473-B2293247-2E47-40EA-91F8-F10BB97EE8EB

P407

Q33398473-92243E73-458C-4443-84CD-E428FEB2706C

P433

Q33398473-4A7578FE-9EE1-4BC1-A2E6-94B9C44A218C

P478

Q33398473-914063CE-9EA9-421F-A21A-58AFE7695CE3

P50

Q33398473-9B04453C-23C2-42A5-A444-8B51037AA204

Q33398473-ECA1CBA7-24E9-49B2-98F0-D448B5526054

P577

Q33398473-B791E0E5-D8B0-4837-956F-8CA12A9EDA83

P698

Q33398473-CF08E934-AAB5-48C1-B7E5-10FB80B77D32

P356

JCO.2010.33.7089

P1433

Journal of Clinical Oncology

P1476

Randomized phase III study of ...... IA non-small-cell lung cancer.

@en

P2093

Carla Visseren-Grul

http://www.w3.org/2001/XMLSchema#string

Francesco Facciolo

http://www.w3.org/2001/XMLSchema#string

Giorgio V Scagliotti

http://www.w3.org/2001/XMLSchema#string

Johan F Vansteenkiste

http://www.w3.org/2001/XMLSchema#string

Luigi Maiorino

http://www.w3.org/2001/XMLSchema#string

Martin Hetzel

http://www.w3.org/2001/XMLSchema#string

Monika Leschinger

http://www.w3.org/2001/XMLSchema#string

Tadeusz M Orlowski

http://www.w3.org/2001/XMLSchema#string

Valter Torri

http://www.w3.org/2001/XMLSchema#string

P304

172-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.33.7089

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Lorenzo Spaggiari

P577

2011-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22124104

http://www.w3.org/2001/XMLSchema#string